TrialActa oncologica (Stockholm, Sweden)2026

How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

Frigg Å Sommervoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.